- Home
- PLPC vs CVAC Comparison
PLPC vs CVAC Comparison
Compare PLPC & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLPC
- CVAC
- Stock Information
- Founded
- PLPC 1947
- CVAC 2000
- Country
- PLPC United States
- CVAC Germany
- Employees
- PLPC N/A
- CVAC N/A
- Industry
- PLPC Water Sewer Pipeline Comm & Power Line Construction
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- PLPC Industrials
- CVAC Health Care
- Exchange
- PLPC Nasdaq
- CVAC Nasdaq
- Market Cap
- PLPC 695.1M
- CVAC 818.8M
- IPO Year
- PLPC N/A
- CVAC 2020
- Fundamental
- Price
- PLPC $134.32
- CVAC $3.30
- Analyst Decision
- PLPC
- CVAC Hold
- Analyst Count
- PLPC 0
- CVAC 3
- Target Price
- PLPC N/A
- CVAC $10.00
- AVG Volume (30 Days)
- PLPC 41.3K
- CVAC 656.5K
- Earning Date
- PLPC 03-06-2025
- CVAC 11-12-2024
- Dividend Yield
- PLPC 0.60%
- CVAC N/A
- EPS Growth
- PLPC N/A
- CVAC N/A
- EPS
- PLPC 6.65
- CVAC N/A
- Revenue
- PLPC $572,200,000.00
- CVAC $70,565,734.00
- Revenue This Year
- PLPC N/A
- CVAC $742.57
- Revenue Next Year
- PLPC N/A
- CVAC N/A
- P/E Ratio
- PLPC $20.21
- CVAC N/A
- Revenue Growth
- PLPC N/A
- CVAC 75.11
- 52 Week Low
- PLPC $109.01
- CVAC $2.22
- 52 Week High
- PLPC $154.90
- CVAC $5.28
- Technical
- Relative Strength Index (RSI)
- PLPC 42.47
- CVAC 39.12
- Support Level
- PLPC $139.19
- CVAC $3.53
- Resistance Level
- PLPC $143.03
- CVAC $3.72
- Average True Range (ATR)
- PLPC 4.12
- CVAC 0.18
- MACD
- PLPC -1.33
- CVAC -0.06
- Stochastic Oscillator
- PLPC 0.06
- CVAC 10.96
About PLPC Preformed Line Products Company
Preformed Line Products Co is a designer and manufacturer of products and systems for constructing and maintaining overhead and underground networks for energy, telecommunication, cable operators, data communication, and other industries. In addition, it provides solar hardware systems and mounting hardware for a variety of solar power applications. Its products consist of Energy Products, Communications Products, and Special Industries Products. The company's majority of the revenue is derived from the sale of products in The Americas with operations also in PLP-USA, Europe, the Middle East and Africa, and Asia-Pacific. The revenue gets driven by Energy products which comprise protecting transmission conductors, spacers, spacer-dampers, and Stockbridge dampers.
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.